NEW YORK, Nov. 18 (GenomeWeb News) - Genetic Technologies of Melbourne, Australia, said today that it has settled lawsuits filed against Nuvelo and Covance for infringement of its non-coding DNA patents.
Genetic Technologies initiated legal action against the two companies and Applera in April 2003.
In a statement today, the company said it "will now dismiss the actions against Nuvelo and Covance," and "plans to "focus its efforts on the remaining action against Applera Corporation."
Specific terms of the settlements were not provided.
The company said it also plans to continue "global expansion of the out-licensing of the GTG non-coding patents" - a controversial strategy that has drawn criticism from the scientific community over the past year.
Genetic Technologies has claimed to be in negotiations with 60 potential licensees worldwide. Licensees and cross-licensees for the company's patents include Orchid Biosciences, Pyrosequencing, Nanogen, and Myriad.